AstraZeneca is a global patient-oriented biopharmaceutical company focused on the research, development, and expansion of access to medications primarily in therapeutic areas such as oncology, cardiology, nephrology, metabolic disorders, respiratory and autoimmune diseases, as well as rare diseases. For over 100 years, AstraZeneca has been developing and producing innovative pharmaceutical products that expand the possibilities of modern medicine and improve patients' lives. AstraZeneca is among the top 5 international biopharmaceutical companies engaged in research and production of prescription medicines in more than 100 countries. Millions of patients worldwide use innovative products manufactured by AstraZeneca.
AstraZeneca's representative office in Kazakhstan was opened in 2007. Currently, the company employs over 220 people across more than 19 cities in the country, including Almaty, Astana, Karaganda, Shymkent, Aktobe, Ust-Kamenogorsk, Uralsk, and others. In 2024 and 2025, the company was recognized as the best employer by the Top Employer Institute. Currently, there are about 30 AstraZeneca products registered in Kazakhstan in therapeutic areas such as oncology, respiratory and autoimmune diseases, cardiovascular diseases, and metabolic disorders.
In September 2023, a Limited Liability Partnership "AstraZeneca Kazakhstan" was registered in Kazakhstan, marking the beginning of a new stage of the company's development in the Republic. The registration of a local legal entity with its own warehouse will allow AstraZeneca to increase its business presence in Kazakhstan, become a more attractive partner for distributors and government bodies, and expand access to innovative therapy for millions of patients in Kazakhstan.

GEROPHARM is an international producer of biotechnology products and a reliable partner in terms of medicinal security in the EAEU countries.
The Company specialises in neurology, endocrinology, ophthalmology, gynaecology, and urology. Currently, GEROPHARM portfolio includes original medicinal products, biosimilar recombinant human insulins and insulin analogs, and generics. In total it is 35 products, including 11 ultra-rapid-, rapid-, intermediate-, and long-acting insulins.
GEROPHARM tops the Russian insulin market and is among the top 10 insulin manufacturers in the world. The Company runs all production stages at its own facilities in Russia, complying with international GxP standards.
In October 2023, GEROPHARM registered Semavic®, Russia's first Ozempic® analog, and issued Semavic®Next, the second product for obesity treatment, similar to Wegovy, in 2024.
Currently, its R&D centre is developing an original innovative ultra-long-acting insulin with a week-long action profile, which is globally peerless.
Medicinal products of the Company are represented in 14 other countries.

LLC "Muse Media", founded in 2017, is the exclusive supplier of NOW Foods, MRM Nutrition, Webber Naturals products in Russia and the winner of the "Platinum Ounce" 2022, the All-Russian open competition for pharmaceutical industry professionals.

NOW Foods produces over 3,500 products (including 900 dietary supplements), recognized in more than 80 countries worldwide, certified by GMP, and meeting the necessary FDA requirements. MRM Nutrition provides high-quality nutrition to consumers worldwide, offering dietary supplements for overall well-being, high sports performance, as well as options for vegans and vegetarians. Webber Naturals manufactures supplements free from artificial colors, sweeteners, GMOs, and gluten. The Sesame Street children's product line is an exclusive range that has long established itself in Canada.

By promoting these products, Muse Media advocates for a responsible approach to health and offers solutions to improve quality and longevity of life.

For over 25 years, Proxima Research has developed products and services in the healthcare sector, enabling clients to achieve new levels of business efficiency.

The company provides expert solutions in market data, CRM/ETMS integration and support, HCP/HCO database management, omnichannel marketing, BI solution implementation, market research, and consulting, with a strong focus on the pharmaceutical industry.

Proxima Research operates based on three core principles:
• Innovation: Continuously exploring new opportunities to develop cutting-edge solutions that drive industry growth.
• Quality: Ensuring that research and products meet the highest standards while taking full responsibility for every aspect of its operations.
• Results: Combining technology, in-depth research, and business expertise to achieve tangible outcomes that help clients expand and thrive.

For more information, visit company website: https://proximaresearch.com/kz/en/

AEQUITAS Law Firm was founded in 1993 and is now among the top Kazakhstan firms recognized on the global legal services market. The top influential ranking agencies, such as Chambers & Partners, The Legal 500, Lexology, and other rank AEQUITAS and its lawyers among the most sought-after experts.

In 2021, 2022, 2023 and 2024, AEQUITAS was awarded as the Firm of the Year in Kazakhstan following the results of Lexology Index Awards (former Who’s Who Lega Awards) organized by Lexology, international ranking agency.

AEQUITAS is active in rendering expert legal services in the sphere of healthcare, medicine and pharmaceuticals.

AEQUITAS clients are the companies from the leading economy sectors from more than 50 countries, which include 20 international, foreign and Kazakhstan companies manufacturing medical and pharmaceutical products, as well as the largest international corporations and companies representing the world-famous brands, banks and financial institutions.
Our core values are high quality of services, honesty, transparency, and efficiency.

VERBA LEGAL is a Russian law firm with an international expertise. We provide services on a wide range of legal issues, using the best SERVICES in combination with international professional standards.

Sona-Pharm is an international pharmaceutical company and part of Sona Group companies, which was established in 2004.
For more than 20 years, Sona-Pharm has been operating in the markets of Ukraine, Kazakhstan, Uzbekistan  and other Central Asia countries with its’ branches in Belarus, Moldova, Georgia, Armenia, and Mongolia.
The Sona Group companies are reliable partners of leading global manufacturers such as Merck (Germany), Lundbeck (Denmark), Biocodex (France), Alfasigma (Italy), Ursapharm (Germany), Pharmathen (Greece), and Visufarma (the Netherlands).
The company provides a full operational cycle for partners, including market analysis, product registration, pharmacovigilance, quality assurance, marketing, and sales. The Portfolio covers key therapeutic areas such as reproductive medicine, neurology, psychiatry, oncology, angiology, gastroenterology, and ophthalmology.